Vol 8, Supplement 1 (October 22, 2019): Chinese Clinical Oncology

Editorial

Ensartinib (X-396) a novel drug for anaplastic lymphoma kinase-positive non-small cell lung cancer patients: we need smart trials to avoid wasting good bullets

Gianluca Spitaleri, Antonio Passaro, Filippo de Marinis

PDF Pages: S1 Full Text (1780) Open Access

Digging into lorlatinib resistance in ALK-positive lung cancer: an editorial

Francesco Facchinetti, Marcello Tiseo

PDF Pages: S2 Full Text (3684) Open Access

Does bisphosphonate treatment reduce the risk of future cancer?

Michael Pazianas, Bo Abrahamsen

PDF Pages: S3 Full Text (1829) Open Access

Ensartinib (X-396): what does it add for patients with ALK-rearranged NSCLC

Tianhong Li, Weijie Ma, Eddie C. Tian

PDF Pages: S4 Full Text (3669) Open Access

Perineural invasion in oral cancer: challenges, controversies and clinical impact

Sabrina Daniela da Silva, Luiz Paulo Kowalski

PDF Pages: S5 Full Text (7302) Open Access

Recent changes in the American Joint Commission Cancer staging of human papilloma virus related oropharyngeal cancer: validating the present and envisioning the future

Brett A. Miles

PDF Pages: S6 Full Text (987) Open Access

The dawn of a universal language for an emerging malignancy

Junichi Shindoh

PDF Pages: S7 Full Text (1063) Open Access

The 8th Edition of the American Joint Committee on Cancer (AJCC8) Staging Manual: any improvement in the prognostication of oral tongue cancer?

Alhadi Almangush, Tuula Salo

PDF Pages: S8 Full Text (6124) Open Access

Considering sarcoma staging systems and their implications to personalized care

Rick L. Haas, Michiel A. J. van de Sande

PDF Pages: S9 Full Text (1223) Open Access

Occult breast cancer: the uncommon presentation of a common disease

Angela Toss, Luca Moscetti, Stefano Cascinu

PDF Pages: S10 Full Text (6504) Open Access

Breast cancer prognostic staging and internal mammary lymph node metastases: a brief overview

Jennifer K. Plichta

PDF Pages: S11 Full Text (4426) Open Access

Staging systems and nomograms in soft tissue sarcoma: outcome prediction by categorization or personalization?

William W. Tseng, Sandro Pasquali, James S. Hu, Lawrence R. Menendez, Alessandro Gronchi

PDF Pages: S12 Full Text (1646) Open Access

Unlocking the potential with the use of check-point inhibitor immunotherapies in metastatic prostate cancer

Swaroop Revannasiddaiah, Ishu Gupta, Santhosh Kumar Devadas

PDF Pages: S13 Full Text (1012) Open Access

Emerging new predictive biomarkers in metastatic breast cancer: Caveolin-1 and weekly nab-paclitaxel plus gemcitabine, are we on for tomorrow?

Francesco Ricci, Christophe Le Tourneau

PDF Pages: S14 Full Text (1566) Open Access

What can National Registry data tell us about occult breast cancer?

John Benjamin Wild, Steven Thrush, Raghavan Vidya

PDF Pages: S15 Full Text (1439) Open Access

Impact of hypochloremia in resected colorectal cancer patients

Mai Tsutsui, Seiichiro Yamamoto

PDF Pages: S16 Full Text (2148) Open Access

A step ahead on CTHRC1, and not just reinventing the wheel!

Siddharth Turkar, Anant Ramaswamy, Vikas Ostwal

PDF Pages: S17 Full Text (1650) Open Access

Editorial Commentary

Relevant changes in the AJCC 8th edition staging manual for oral cavity cancer and future implications

Luiz Paulo Kowalski, Hugo Fontan Köhler

PDF Pages: S18 Full Text (4050) Open Access

AJCC 8^th edition staging system for pathologically versus clinically staged intrahepatic cholangiocarcinoma (iCCA): ready for prime time?

Daniel H. Ahn, Tanios Bekaii-Saab

PDF Pages: S19 Full Text (1936) Open Access

Bevacizumab is more effective in nasopharyngeal carcinoma patients with lower maximum radiation dose to the temporal lobe

Adam Garsa, Jennifer C. Ho, Chaosu Hu, Eric L. Chang

PDF Pages: S20 Full Text (1913) Open Access

Pembrolizumab plus axitinib: a new treatment option for patients with metastatic renal cell carcinoma

Veronica Mollica, Vincenzo Di Nunno, Francesco Massari

PDF Pages: S21 Full Text (3680) Open Access

Chemotherapy of pancreatic cancer in patients with poor performance

Dominik Schulz, Hana Algül

PDF Pages: S22 Full Text (2002) Open Access

Perioperative safety in patients with resectable synchronous colorectal liver metastases

Lucas D. Lee, Y. Nancy You

PDF Pages: S23 Full Text (1412) Open Access

Immune subgroups and the tumor microenvironment as a potential new biomarker to assess response to immunotherapy

Shawn Kothari, Everett E. Vokes

PDF Pages: S24 Full Text (2796) Open Access

More options for older patients with acute myeloid leukemia: venetoclax in combination with low dose cytarabine

Ibrahim Aldoss, Guido Marcucci

PDF Pages: S25 Full Text (2600) Open Access

Is it time for a specific score for venous thromboembolism risk assessment for non-solid tumors?

Ariane Vieira Scarlatelli Macedo, Eduardo Ramacciotti

PDF Pages: S26 Full Text (1245) Open Access

Letter to the Editor

A closer look at the staging of soft tissue sarcomas in an era of personalized medicine

Aileen C. Johnson, Kenneth Cardona

PDF Pages: S27 Full Text (986) Open Access

Obituary

In memory of Dr. Henry T. Lynch

Daniel G. Haller

PDF Pages: S28 Full Text (1167) Open Access

Disclosure:

The supplement was published without any sponsorship or funding.